As per DelveInsight’s assessment, globally, Chronic Lower Back Pain pipeline constitutes 10+ key companies continuously ...

In January 2025, Agios Pharmaceuticals (AGIO) announced that the FDA has accepted its supplemental new drug application (sNDA ...